NASDAQ$AVAH

Aveanna Healthcare Holdings Inc · Q1 2026 earnings

Q1 2026 earnings ·

Briefing

Aveanna Healthcare reported Q1 2026 net revenue of $647.9M in home-based care services.

For the quarter ended April 4, 2026, Aveanna Healthcare reported net revenue of approximately $647.9 million in its pediatric and adult home health, hospice, and private duty nursing segments. The company serves medically complex patients; MD&A discusses reimbursement rates, labor costs, and acquisition integration.

  • Net revenue ~$647.9M for fiscal Q1 2026.
  • Home health and hospice platform with national footprint.
  • Labor availability and wage inflation key margin drivers.
  • Medicaid and managed care payor mix dominates revenue.
  • Deleveraging and synergy targets from prior acquisitions.

Headline financials

Total Revenue

$648M

Previous: $559M+15.9%
EPS (adj)

$0.19

Previous: $0.03+533.3%
Net Income

$41.7M

Previous: $5.19M+702.1%
Operating Income

$69.3M

Previous: $51.8M+33.8%
Gross Profit

$205M

Previous: $184M+11.9%

Revenue & EPS history

Aveanna Healthcare Holdings Inc · Revenue · Quarterly

$648M

Q1 2026+15.9%vs Q1 2025
Beat estimate in 1 of 1 quarters(100%)
ActualEstimate

Forward guidance

Home health providers may give annual EBITDA guidance on calls; 10-Q focuses on reimbursement updates and labor metrics.

Tailwinds

  • Large-scale platform in growing home-based care market.
  • Diversified payor and service lines.

Headwinds

  • Nursing labor shortages and wage pressure.
  • Medicaid rate risk in key states.
  • Leverage from acquisition history.

Historical earnings impact

How earnings announcements have historically affected this stock's price.

Avg. return before/after earnings

Based on 14 quarterly earnings reports · overlaid with Q1 2026

Historical avgQ1 2026

+2.7%

Avg return

Earnings day

+5.0%

Avg return

5 days after

+8.2%

Avg return

30 days after

56%

9 / 16 earnings

Positive

+32.2%

Q2 2024

Best reaction

-8.6%

Q2 2022

Worst reaction

Earnings price reactions
QuarterReport dateReaction (Day 0)+5 days+30 days
Q1 2026+9.4%+12.2%+4.4%
Q4 2025-8.2%-4.3%-2.0%
Q3 2026-6.3%-2.5%+1.1%
Q1 2025+14.1%+21.6%+14.3%
Q3 2024+16.2%+20.6%+11.4%
Q2 2024+32.2%+34.4%+58.0%
Q1 2024+2.5%+6.2%+2.9%
Q3 2023+2.0%+26.2%+75.8%
Q2 2023+3.4%+0.6%-21.0%
Q1 2023+3.8%+5.7%+26.7%
Q3 2022-8.3%-19.4%-13.7%
Q2 2022-8.6%-9.1%-12.9%
Q1 2022-6.5%+5.4%+4.0%
Q3 2021-3.1%-16.5%-25.9%
Q2 2021+2.3%-2.0%-2.9%
Q1 2021-1.8%+0.9%+10.4%

Discussion

Share your read of this quarter. Sign-in carries your eToro identity.

Join the conversation

Sign in with eToro to post your read of this quarter and vote on others'.

Sign in with eToro